Aztreonam

Description

Aztreonam exhibits activity in vitro against gram-negative aerobic pathogens, including P. aeruginosa. Aztreonam binds to penicillin-binding proteins of susceptible bacteria, which leads to inhibition of bacterial cell wall synthesis, followed by filamentation and cell lysis.

Medicine classification

ATC Code
Title
Class
J01DF01
Aztreonam
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DF Monobactams

Medicines

Drug
Countries
AZACTAM

Austria France Singapore Spain United Kingdom

CAYSTON

Austria Canada Cyprus France Lithuania

Product monographs

Monograph
Type
Country
CAYSTON Powder and solvent for nebuliser solution
MPI, EU: SmPC
AZACTAM Powder for solution for injection or infusion
MPI, EU: SmPC
UK

2D Molecule Structure

2D representation of molecule

3D Molecule Structure

3D representation of molecule

Unique Ingredient Identifier (UNII)

G2B4VE5GH8 - AZTREONAM

CAS Registry Number

78110-38-0 - aztreonam

SNOMED-CT

387386004 - Aztreonam (substance)

Usage: Next >